Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Curious about your investment portfolio? Discover what to include to ensure a balanced and profitable mix of assets.
23,656 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
As offshore energy demand shifts, investors face a clear choice: TechnipFMC or Valaris. This guide breaks down how ea...
Investors eye dividend income to replace a $70,000 salary. This piece breaks down three yield-based paths and the cap...
Semiconductors took the spotlight as Micron sparked a broader tech rally. TheNasdaq led gains while the S&P 500 and D...
Sotera Health has delivered a solid return over the last 12 months. Yet a sizable fund recently unloaded millions of ...
As remitly gears up for 2025, investors should focus on growth drivers, margin potential, and the risks that could sh...
Mission Produce enters 2026 with a mix of hedges, growing demand, and a tight supply chain. This guide breaks down wh...
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
Hyperscale AI demand is tightening packaging capacity. Intel's EMIB-T presents a potential workaround as chip packagi...
A voluntary recall of thousands of Waymo AVs grabbed headlines, but the bigger story is the decade ahead for autonomo...
Pony AI's Q1 2026 earnings transcript is a pivotal moment for investors. This article breaks down the key numbers, th...
A nuclear startup teams with a national lab to speed up reactor design using AI. This piece breaks down what it could...